![Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/958739e4-32fb-4592-a516-73abe8293179/gr1.jpg)
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews
![SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12. - Abstract - Europe PMC SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6985262/bin/41419_2020_2266_Fig2_HTML.jpg)
SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12. - Abstract - Europe PMC
![Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy](https://www.mdpi.com/cancers/cancers-11-00628/article_deploy/html/images/cancers-11-00628-g001.png)
Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
![Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology](https://www.researchgate.net/profile/Pablo-Moreno-Ruiz/publication/354658184/figure/fig2/AS:1069069377748993@1631897410190/PD-L1-expression-levels-in-breast-cancer-patient-tissue-PD-L1-protein-expression-using_Q320.jpg)
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
![Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology](https://i1.rgstatic.net/ii/profile.image/995374651166726-1614327218417_Q128/Caroline-Kamali-2.jpg)
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
![Frontiers | The Role of Statins in Prevention of Preeclampsia: A Promise for the Future? | Pharmacology Frontiers | The Role of Statins in Prevention of Preeclampsia: A Promise for the Future? | Pharmacology](https://www.frontiersin.org/files/Articles/229118/fphar-08-00247-HTML/image_m/fphar-08-00247-g001.jpg)
Frontiers | The Role of Statins in Prevention of Preeclampsia: A Promise for the Future? | Pharmacology
![Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - ScienceDirect Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737221001055-gr2.jpg)
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - ScienceDirect
![SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12 | Cell Death & Disease SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12 | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-2266-x/MediaObjects/41419_2020_2266_Fig3_HTML.png)
SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12 | Cell Death & Disease
![Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease - Zerdes - 2020 - Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease - Zerdes - 2020 -](https://febs.onlinelibrary.wiley.com/cms/asset/e9ec5994-dcda-4efd-ba36-eda88545f954/mol212654-toc-0001-m.jpg)
Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease - Zerdes - 2020 -
![Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations | Oncogene Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations | Oncogene](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41388-018-0303-3/MediaObjects/41388_2018_303_Fig1_HTML.jpg)
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations | Oncogene
![The outcome-based / feedback paradigm differentiates strong and weak learning outcomes, learner diversity, and the learning outcomes of each learner: A shift to metacognitive assessment The outcome-based / feedback paradigm differentiates strong and weak learning outcomes, learner diversity, and the learning outcomes of each learner: A shift to metacognitive assessment](https://sciendo-parsed-data-feed.s3.eu-central-1.amazonaws.com/6009128e65bc035eda944926/cover-image.jpg)
The outcome-based / feedback paradigm differentiates strong and weak learning outcomes, learner diversity, and the learning outcomes of each learner: A shift to metacognitive assessment
![PDF] Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy | Semantic Scholar PDF] Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b35807a7b2a40d1d66ecfaf04ea6916752e28c9b/38-Table5-1.png)
PDF] Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy | Semantic Scholar
![Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer](https://www.mdpi.com/cancers/cancers-11-01479/article_deploy/html/images/cancers-11-01479-g005.png)
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
![Immune gene expression and response to chemotherapy in advanced breast cancer | British Journal of Cancer Immune gene expression and response to chemotherapy in advanced breast cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2017.446/MediaObjects/41416_2018_Article_BFbjc2017446_Fig1_HTML.jpg)
Immune gene expression and response to chemotherapy in advanced breast cancer | British Journal of Cancer
![Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub. Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.](https://cyberleninka.org/viewer_images/104404/f/1.png)
Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
![Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology](https://www.researchgate.net/profile/Pablo-Moreno-Ruiz/publication/354658184/figure/fig3/AS:1069069377757184@1631897410624/PD-L1-expression-levels-in-different-immune-cell-types-using-a-multiplex-fluorescent_Q320.jpg)